Ketoconazole/Clobetasol Propionate/Fradiomycin sulfate

酮康唑/丙酸氯倍他索/硫酸新霉素

Report date: 2025/11/17 14:45:38
NME

Base Information

Drug NameKetoconazole/Clobetasol Propionate/Fradiomycin sulfate
Drug Alias NameN/A
ClassificationSmall molecules > Steroids
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsGlucocorticoid receptor agonistsBacterial penicillin-binding protein inhibitors
TargetsLanosterol 14α-demethylaseGlucocorticoid receptorBacterial penicillin-binding protein
Therapy Area/IndicationsDermatomycoses
Global Approved IndicationsDermatomycoses
Approved Indications in ChinaDermatomycoses
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryMainland China
CombinationsYes KetoconazoleClobetasol PropionateFradiomycin sulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Hengjian Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Cr Shunfeng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatomycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A